ULTRAFEM INC
8-K, 1998-01-30
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: DEFINED ASSET FUNDS CORPORATE INCOME FUND INSD SER 16, 497, 1998-01-30
Next: SUNAMERICA SERIES TRUST, 485APOS, 1998-01-30



<PAGE>


                          SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C.  20549


                                       FORM 8-K

                                    CURRENT REPORT

                        Pursuant to Section 13 or 15(d) of the
                           Securities Exchange Act of 1934



          Date of Report (Date of earliest event reported): January 28, 1998


                                    ULTRAFEM, INC.
                ------------------------------------------------------
                (Exact name of registrant as specified in its charter)



        Delaware                      0-27576                 33-0435037
- ---------------------------  -------------------------  ----------------------
(State or otherjurisdiction   (Commission File Number)        (IRS Employer
   of incorporation)                                        Identification No.)

         805 Third Avenue, 17th Floor, New York, New York     10022   
    ----------------------------------------------------------------------
      (Address of principal executive offices)              (Zip Code)


    Registrant's telephone number, including area code:  (212) 446-1400



                                  NOT APPLICABLE                             
           ------------------------------------------------------------
           (Former name or former address, if changed since last report)



<PAGE>

Item 5.   Other Events.

          On January 28, 1998, Ultrafem, Inc. issued the press release (the
"Press Release") annexed as an exhibit hereto.  The Press Release is
incorporated herein by reference.
          
Item 7.   Financial Statements and Exhibits.

          (c)  Exhibits.

               99.2 Press Release of Ultrafem, Inc. dated January 28, 1998.
                








                                       -2-

<PAGE>


                                      SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                   ULTRAFEM, INC.
                                   (Registrant)


Dated:   January 30, 1998          By:  /s/ Dori M. Reap
                                      ------------------------------------
                                       Dori M. Reap
                                       Office of the Chief Executive,
                                       Senior Vice President, Finance and
                                       Administration, Secretary and Chief
                                       Financial Officer
 




                                       -3-


<PAGE>
                                 INDEX TO EXHIBITS
                                          
                                          
Exhibit No.                                            Page No.
- -----------                                            --------

99.2 Press Release of Ultrafem, Inc.              
     dated January 28, 1998







                                       -4-



<PAGE>


[LOGO]

                                                       For Further Information,
                                                                Please Contact:
                                                               Philip L. Thomas
                                                    The P.L. Thomas Group, Inc.
                                                                   312/906-8060



                 ULTRAFEM ANNOUNCES SENIOR MANAGEMENT CHANGES

   NEW YORK, NY, JANUARY 28, 1998 -- The Board of Directors of Ultrafem, Inc. 
(Nasdaq:UFEM) announced the termination of the Company's employment 
arrangements with John Andersen, Chief Executive Officer and President, and 
Audrey Contente, Executive Vice President. The Board has begun a search for a 
new Chief Executive Officer and President. Pending the appointment of a new 
Chief Executive Officer, the Company has established the Office of the Chief 
Executive consisting of Dori M. Reap, Senior Vice President Finance, and 
Tonya G. Hinch, Senior Vice President Marketing and Sales, according to Joy 
V. Jones who has been named as Chairperson of the Board of Directors.

Ms. Jones said, "The Board has initiated this restructuring to facilitate the 
Company's efforts with respect to a financing and other alternatives, 
including the potential sale of the Company, its individual assets or 
distribution rights." The Board also formed an Executive Committee consisting 
of Richard A. Cone, Joy V. Jones, Martin Nussbaum and Charles D. Peebler, Jr. 
Further, Mr. Andersen and Ms. Contente will remain Directors of the Company.

Ultrafem is a women's health care company. The Company's business strategy is 
to develop, manufacture and market proprietary products based on its patented 
SoftCup-Registered Trademark- Technology directed at high potential, 
underserved segments of the women's health care market. The Company completed 
an initial public offering in February 1996 and a secondary financing in 
November 1996 to support the launch of its first commercial product, 
INSTEAD-Registered Trademark-.

The statements contained in this release which are not historical facts are 
forward-looking statements that involve risks and uncertainties. Such risks 
include, but are not limited to, the changing priorities of customers, other 
marketing risks, potential competitive response, and the need for additional 
financing to successfully market and distribute INSTEAD-Registered Trademark- 
as well as for unforeseen risks, among other factors affecting the business 
which are described in the Company's filings with the Securities and Exchange 
Commission. Management wishes to caution the reader that any forward-looking 
statements are only predictions; actual events or results may differ 
materially as a result of risks facing the Company.

                                   ## ## ##



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission